Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-09 Purchase |
2025-04-11 9:57 pm |
Keros Therapeutics Inc. | KROS | ADAR1 Capital Management LLC ADAR1 Partners LP ADAR1 Capital Management GP LLC Schneeberger Daniel 10% Owner |
934,258 | $10.13 | $9,464,512 | 5,446,072 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-09 Other |
2025-04-11 9:57 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | ADAR1 Capital Management LLC ADAR1 Partners LP ADAR1 Capital Management GP LLC Schneeberger Daniel 10% Owner |
899,333 | $0 | 5,446,072 (Indirect) |
View |
Ownership |
2025-04-11 8:58 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | ADAR1 Capital Management LLC ADAR1 Partners LP ADAR1 Capital Management GP LLC Schneeberger Daniel 10% Owner |
0 | $0 | 5,539,139 (Indirect) |
View |
Ownership |
2021-05-06 8:41 pm |
N/A N/A |
Anebulo Pharmaceuticals Inc. | ANEB | Schneeberger Daniel Chief Executive Officer |
0 | $0 | 982,500 (Direct) |
View |